Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| BEYFORTUS | Sanofi Pasteur Limited | Marketed | Oct 21, 2024 | Marketed |
| XENPOZYME | SANOFI-AVENTIS CANADA INC | Marketed | Oct 18, 2024 | Marketed |
| ASPARLAS | servier canada inc | Marketed | Oct 16, 2024 | Marketed |
| AXBERI | baxter corporation | Marketed | Oct 15, 2024 | Marketed |
| AXBERI | baxter corporation | Marketed | Oct 15, 2024 | Marketed |
| AXBERI | baxter corporation | Marketed | Oct 15, 2024 | Marketed |
| AZACITIDINE FOR INJECTION | fresenius kabi canada ltd | Marketed | Oct 15, 2024 | Marketed |
| AXBERI HP | baxter corporation | Marketed | Oct 15, 2024 | Marketed |
| HYDRATING LIP PROTECTANT STICK SPF 15 | elizabeth arden (canada) limited | Marketed | Oct 10, 2024 | Marketed |
| PEMETREXED DISODIUM FOR INJECTION | EUGIA PHARMA INC. | Marketed | Oct 8, 2024 | Marketed |
| SILEO | ORION CORPORATION | Marketed | Oct 8, 2024 | Marketed |
| EUGIA-ONDANSETRON INJECTION | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| EUGIA-ONDANSETRON INJECTION | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| AZITHROMYCIN FOR INJECTION, USP | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| PEMETREXED DISODIUM FOR INJECTION | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| ROCURONIUM BROMIDE INJECTION | eugia pharma inc. | Marketed | Oct 8, 2024 | Marketed |
| CABTREO | bausch health, canada inc. | Marketed | Oct 7, 2024 | Marketed |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
